Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
WTA Finals tennis : Iga Swiatek v Amanda Anisimova ; Elena Rybakina beats Ekaterina Alexandrova – live
5/11/2025
Mary was not co-redeemer, Vatican says amid spread of cult of the Madonna
5/11/2025
Mamdani refused to compromise on his values – and was rewarded for it | Moustafa Bayoumi
5/11/2025
Second accidental release of prisoner ‘utterly unacceptable’, No 10 says, as Lammy blames system left by Tories – UK politics live
5/11/2025
Helen Mirren to receive Golden Globe lifetime achievement award
5/11/2025
France moves to suspend Shein over sex dolls as debut store opens in Paris
5/11/2025